Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant: genes and variants

Explore variant evidence for Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant across 1 analyzed protein (GRIN1). Linked ClinVar records include 55 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 42 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-10-15. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant

Where Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant

VariantPositionProtein partClinical label
GRIN1 R844C844CytoplasmicPathogenic / likely pathogenic (★★★★)
GRIN1 G618R618Pore-formingPathogenic / likely pathogenic (★★)
GRIN1 M641L641TransmembranePathogenic / likely pathogenic (★★)
GRIN1 M641V641TransmembranePathogenic / likely pathogenic (★★)
GRIN1 R794Q794ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 P557L557ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 G620R620Pore-formingPathogenic / likely pathogenic (★★)
GRIN1 R659W659ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 R659Q659ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 G638A638TransmembranePathogenic / likely pathogenic (★★)
GRIN1 M818L818TransmembranePathogenic / likely pathogenic (★★)
GRIN1 R844L844CytoplasmicPathogenic / likely pathogenic (★★)
GRIN1 D227H227ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 S549R549ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 G633V633TransmembranePathogenic / likely pathogenic (★★)
GRIN1 I643V643TransmembranePathogenic / likely pathogenic (★★)
GRIN1 P805L805ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 G827R827TransmembranePathogenic / likely pathogenic (★★)
GRIN1 S688Y688ExtracellularPathogenic / likely pathogenic (★★)
GRIN1 G618V618Pore-formingPathogenic / likely pathogenic (★)
GRIN1 M641T641TransmembranePathogenic / likely pathogenic (★)
GRIN1 M641I641TransmembranePathogenic / likely pathogenic (★)
GRIN1 R794P794ExtracellularPathogenic / likely pathogenic (★)
GRIN1 R794G794ExtracellularPathogenic / likely pathogenic (★)
GRIN1 M818R818TransmembranePathogenic / likely pathogenic (★)
GRIN1 M555I555ExtracellularPathogenic / likely pathogenic (★)
GRIN1 M555T555ExtracellularPathogenic / likely pathogenic (★)
GRIN1 Q556H556ExtracellularPathogenic / likely pathogenic (★)
GRIN1 Q556R556ExtracellularPathogenic / likely pathogenic (★)
GRIN1 N616S616Pore-formingPathogenic / likely pathogenic (★)
GRIN1 S617F617Pore-formingPathogenic / likely pathogenic (★)
GRIN1 V635G635TransmembranePathogenic / likely pathogenic (★)
GRIN1 A640P640TransmembranePathogenic / likely pathogenic (★)
GRIN1 I642T642TransmembranePathogenic / likely pathogenic (★)
GRIN1 V644A644TransmembranePathogenic / likely pathogenic (★)
GRIN1 A645S645TransmembranePathogenic / likely pathogenic (★)
GRIN1 Y647H647TransmembranePathogenic / likely pathogenic (★)
GRIN1 V656G656ExtracellularPathogenic / likely pathogenic (★)
GRIN1 V793F793ExtracellularPathogenic / likely pathogenic (★)
GRIN1 M813T813TransmembranePathogenic / likely pathogenic (★)
GRIN1 G815R815TransmembranePathogenic / likely pathogenic (★)
GRIN1 V816F816TransmembranePathogenic / likely pathogenic (★)
GRIN1 F817L817TransmembranePathogenic / likely pathogenic (★)
GRIN1 Q405L405ExtracellularPathogenic / likely pathogenic (★)
GRIN1 K483Q483ExtracellularPathogenic / likely pathogenic (★)
GRIN1 N650K650ExtracellularPathogenic / likely pathogenic (★)
GRIN1 C744Y744ExtracellularPathogenic / likely pathogenic (★)
GRIN1 D789N789ExtracellularPathogenic / likely pathogenic (★)
GRIN1 A806E806ExtracellularPathogenic / likely pathogenic (★)
GRIN1 E172K172ExtracellularPathogenic / likely pathogenic (★)
GRIN1 W611L611Discontinuously helicalPathogenic / likely pathogenic (★)
GRIN1 K531R531ExtracellularPathogenic / likely pathogenic (★)
GRIN1 E662K662ExtracellularPathogenic / likely pathogenic
GRIN1 D552E552ExtracellularPathogenic / likely pathogenic
GRIN1 F654C654ExtracellularPathogenic / likely pathogenic

Uncertain variants prioritized for review in Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant

VariantPositionProtein partClinical labelEvidence
GRIN1 R794L794ExtracellularConflicting reports (★)+6: 4 other pathogenic changes within 3 positions; R794P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.82
GRIN1 G815W815TransmembraneConflicting reports (★)+6: 6 other pathogenic changes within 3 positions; G815R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GRIN1 S617C617Pore-formingConflicting reports (★)+6: 5 other pathogenic changes within 3 positions; S617F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98
GRIN1 A806V806ExtracellularConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; A806E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91
GRIN1 G815E815TransmembraneUncertain (★)+6: 6 other pathogenic changes within 3 positions; G815R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GRIN1 F654S654ExtracellularUncertain (★)+6: 2 other pathogenic changes within 3 positions; F654C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GRIN1 I643T643TransmembraneUncertain (★)+6: 9 other pathogenic changes within 3 positions; I643V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97
GRIN1 G638S638TransmembraneUncertain (★)+6: 7 other pathogenic changes within 3 positions; G638A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98

Which prediction tools work for Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Diseases related to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant

Frequently asked questions

Which genes have records linked to Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant?

This view contains 1 analyzed proteins: GRIN1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 55 pathogenic or likely pathogenic variants, 179 variants of uncertain significance and 42 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 8 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 313 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center